It’s an exciting time here at Pirouette HQ! We just received a Notice of Award from the NIH – they have awarded us an administrative supplement of $97K+ to expand the scope of our Phase I award! 💸🔬 The Phase I award has been crucial in affirming the technical merit and commercial potential of our Naloxone HCl auto-injector. With this expanding scope, we can accelerate our progress toward FDA approval and commercialization, bringing us closer to saving lives. 🙌 NIH SEED https://lnkd.in/epgze9eF
Congrats, Conor!
Ignite the spark : Imagine, Innovate, and Inspire...
3moLove it, Conor!! Best wishes.